Your browser doesn't support javascript.
loading
Rapid adaptation to CDK2 inhibition exposes intrinsic cell-cycle plasticity.
Arora, Mansi; Moser, Justin; Hoffman, Timothy E; Watts, Lotte P; Min, Mingwei; Musteanu, Monica; Rong, Yao; Ill, C Ryland; Nangia, Varuna; Schneider, Jordan; Sanclemente, Manuel; Lapek, John; Nguyen, Lisa; Niessen, Sherry; Dann, Stephen; VanArsdale, Todd; Barbacid, Mariano; Miller, Nichol; Spencer, Sabrina L.
Afiliación
  • Arora M; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Moser J; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Hoffman TE; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Watts LP; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Min M; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA; Guangzhou Laboratory, Guangzhou, Guangdong, China.
  • Musteanu M; Experimental Oncology Group, Molecular Oncology Programme, Spanish National Cancer Research Centre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Rong Y; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA; Department of Molecular, Cellular, and Developmental Biology and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Ill CR; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Nangia V; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Schneider J; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA.
  • Sanclemente M; Experimental Oncology Group, Molecular Oncology Programme, Spanish National Cancer Research Centre, Madrid, Spain.
  • Lapek J; Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA 92121, USA.
  • Nguyen L; Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA 92121, USA.
  • Niessen S; Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA 92121, USA.
  • Dann S; Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA 92121, USA.
  • VanArsdale T; Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA 92121, USA.
  • Barbacid M; Experimental Oncology Group, Molecular Oncology Programme, Spanish National Cancer Research Centre, Madrid, Spain; Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • Miller N; Oncology Research & Development, Pfizer Worldwide Research & Development, San Diego, CA 92121, USA.
  • Spencer SL; Department of Biochemistry and BioFrontiers Institute, University of Colorado-Boulder, Boulder, CO 80303, USA. Electronic address: sabrina.spencer@colorado.edu.
Cell ; 186(12): 2628-2643.e21, 2023 06 08.
Article en En | MEDLINE | ID: mdl-37267950
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinasas Ciclina-Dependientes / Proteínas de Ciclo Celular Límite: Animals Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Quinasas Ciclina-Dependientes / Proteínas de Ciclo Celular Límite: Animals Idioma: En Revista: Cell Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos